Robert G. Moussa is Director at DERMA SCIENCES, INC. (DSCI). They have made 7 open-market trades across 2 companies since 2006, most recently 2017-02-24.
CIK 0001012788
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
6 open-market purchases totalling $216.1M since 2006, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| DSCI | BUY | 2015-08-13 | 2015-08-14 | $6.61 | $33K | N/A | N/A | N/A |
| DSCI | SELL | 2011-02-10 | 2011-02-11 | $12.60 | $63K | N/A | N/A | N/A |
| DSCI | BUY | 2008-09-19 | 2008-09-22 | $10800.00 | $216.0M | N/A | N/A | N/A |
| DSCI | BUY | 2007-12-03 | 2007-12-03 | $0.65 | $13K | N/A | N/A | N/A |
| DXR | BUY | 2006-10-31 | 2006-10-31 | $15.29 | $8K | -2.7% | -0.7% | -0.7% |
| DSCI | BUY | 2006-08-30 | 2006-08-31 | $0.74 | $11K | N/A | N/A | N/A |
| DXR | BUY | 2006-06-16 | 2006-06-20 | $17.84 | $9K | -2.7% | -0.7% | -0.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.